In Episode 56 of Bladder Cancer Matters, host Rick Bangs talks with Dr. Matthew Galsky, a medical oncologist who specializes in treating bladder cancer patients, about advancing new treatments for bladder cancer through clinical development and investigating the gap between the efficacy and real-world effectiveness of existing chemotherapies. Among other topics, they discuss:  The VESPER trial and its purpose related to bladder cancer Background on two chemotherapies, MVAC and GemCis, for muscle invasive bladder cancer The side effects of both chemotherapy regimens Identifying who requires treatment and who benefits from it Other promising developments occurring in the field of chemotherapy for the initial treatment of bladder cancer patients Never miss an episode by subscribing to our podcast. Simply search for “Bladder Cancer Matters” on your favorite podcast and click the “subscribe” button.

Ver todos los episodios